Trofinetide for the Treatment of Rett Syndrome: Results From the Open-Label LILAC Study

被引：0
|
作者：
Percy, A.
Neul, J.
Benke, T.
Berry-Kravis, E.
Glaze, D.
Marsh, E.
An, D.
Bishop, K.
Youakim, J.
机构：
来源：
ANNALS OF NEUROLOGY | 2023年 / 94卷
关键词：
Neurodevelopmental Disorders;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
178
引用
收藏
页码：S94 / S95
页数：2
相关论文
共 50 条
  • [1] Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC study
    Percy, Alan K.
    Neul, Jeffrey L.
    Benke, Timothy A.
    Berry-Kravis, Elizabeth M.
    Glaze, Daniel G.
    Marsh, Eric D.
    An, Di
    Bishop, Kathie M.
    Youakim, James M.
    MED, 2024, 5 (09):
  • [2] Trofinetide for the treatment of Rett syndrome Long-term safety and efficacy results of the 32-month, open-label LILAC-2 study
    Percy, Alan K.
    Neul, Jeffrey L.
    Benke, Timothy A.
    Berry-Kravis, Elizabeth M.
    Glaze, Daniel G.
    Marsh, Eric D.
    Barrett, Amy M.
    An, Di
    Bishop, Kathie M.
    Youakim, James M.
    MED, 2024, 5 (10):
  • [3] Trofinetide for the treatment of Rett syndrome: an open-label study in girls 2 to 4 years of age ()
    Percy, Alan
    Ryther, Robin
    Marsh, Eric
    Feyma, Timothy
    Lieberman, David
    Neul, Jeffrey
    Benke, Timothy
    Glaze, Daniel
    Berry-Kravis, Elizabeth
    Ananth, Amitha
    Buhrfiend, Colleen
    Stankovic, Srdjan
    Bishop, Kathie
    Darwish, Mona
    Youakim, James
    NEUROLOGY, 2023, 100 (17)
  • [4] An open-label study of trofinetide for the treatment of Rett syndrome in girls 2 to 4 years of age
    Percy, A.
    Ryther, R.
    Marsh, E.
    Feyma, T.
    Lieberman, D.
    Neul, J.
    Benke, T.
    Glaze, D.
    Berry-Kravis, E.
    Ananth, A.
    Buhrfiend, C.
    Stankovic, S.
    Bishop, K.
    Darwish, M.
    Youakim, J.
    Arkilo, D.
    ANNALS OF NEUROLOGY, 2022, 92 : S191 - S192
  • [5] Trofinetide: a pioneering treatment for Rett syndrome
    Parent, Harrison
    Ferranti, Anthony
    Niswender, Colleen
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2023, 44 (10) : 740 - 741
  • [6] Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study
    Neul, Jeffrey L.
    Percy, Alan K.
    Benke, Timothy A.
    Berry-Kravis, Elizabeth M.
    Glaze, Daniel G.
    Marsh, Eric D.
    Lin, Tim
    Stankovic, Serge
    Bishop, Kathie M.
    Youakim, James M.
    NATURE MEDICINE, 2023, 29 (06) : 1468 - +
  • [7] Development of trofinetide for the treatment of Rett syndrome: from bench to bedside
    Kennedy, Melissa
    Glass, Larry
    Glaze, Daniel G.
    Kaminsky, Steve
    Percy, Alan K.
    Neul, Jeffrey L.
    Jones, Nancy E.
    Tropea, Daniela
    Horrigan, Joseph P.
    Nues, Paige
    Bishop, Kathie M.
    Youakim, James M.
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [8] Randomized open-label trial of dextromethorphan in Rett syndrome
    Smith-Hicks, Constance L.
    Gupta, Siddharth
    Ewen, Joshua B.
    Hong, Manisha
    Kratz, Lisa
    Kelley, Richard
    Tierney, Elaine
    Vaurio, Rebecca
    Bibat, Genila
    Sanyal, Abanti
    Yenokyan, Gayane
    Brereton, Nga
    Johnston, Michael V.
    Naidu, Sakkubai
    NEUROLOGY, 2017, 89 (16) : 1684 - 1690
  • [9] Trofinetide treatment for Rett syndrome: Lessons to learn
    Tropea, Daniela
    MED, 2024, 5 (10): : 1194 - 1196
  • [10] Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study
    Jeffrey L. Neul
    Alan K. Percy
    Timothy A. Benke
    Elizabeth M. Berry-Kravis
    Daniel G. Glaze
    Eric D. Marsh
    Tim Lin
    Serge Stankovic
    Kathie M. Bishop
    James M. Youakim
    Nature Medicine, 2023, 29 : 1468 - 1475
12345